Charles River Laboratories International, Inc. (CRL)
Company Info
| ISIN | US1598641074 |
|---|---|
| CUSIP | 159864107 |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
Highlights
| Market Cap | $11.68B |
|---|---|
| EPS | $9.23 |
| PE Ratio | 24.57 |
| PEG Ratio | 1.87 |
| Revenue (TTM) | $4.13B |
| Gross Profit (TTM) | $1.46B |
| EBITDA (TTM) | $970.29M |
| Year Range | $161.65 - $275.00 |
| Target Price | $270.80 |
| Short % | 3.99% |
| Short Ratio | 3.18 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: CRL vs. VOO, CRL vs. ADSK, CRL vs. DGX, CRL vs. SPY, CRL vs. DHR, CRL vs. ILMN
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Charles River Laboratories International, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Charles River Laboratories International, Inc. had a return of 1.58% year-to-date (YTD) and 17.81% in the last 12 months. Over the past 10 years, Charles River Laboratories International, Inc. had an annualized return of 15.57%, outperforming the S&P 500 benchmark which had an annualized return of 10.55%.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 1.58% | 6.30% |
| 1 month | -11.90% | -3.13% |
| 6 months | 30.75% | 19.37% |
| 1 year | 17.81% | 22.56% |
| 5 years (annualized) | 11.42% | 11.65% |
| 10 years (annualized) | 15.57% | 10.55% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -8.51% | 17.53% | 6.59% | |||||||||
| 2023 | -5.24% | -14.09% | 17.06% | 19.95% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
Charles River Laboratories International, Inc.(CRL)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Charles River Laboratories International, Inc. (CRL) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Charles River Laboratories International, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Charles River Laboratories International, Inc. was 69.81%, occurring on Nov 20, 2008. Recovery took 1545 trading sessions.
The current Charles River Laboratories International, Inc. drawdown is 47.60%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -69.81% | Aug 20, 2008 | 66 | Nov 20, 2008 | 1545 | Jan 13, 2015 | 1611 |
| -64.1% | Sep 27, 2021 | 527 | Oct 30, 2023 | — | — | — |
| -47.06% | Oct 2, 2000 | 111 | Mar 12, 2001 | 78 | Jul 2, 2001 | 189 |
| -44.54% | Feb 20, 2020 | 20 | Mar 18, 2020 | 50 | May 29, 2020 | 70 |
| -39.6% | Oct 24, 2002 | 118 | Apr 14, 2003 | 209 | Feb 11, 2004 | 327 |
Volatility
Volatility Chart
The current Charles River Laboratories International, Inc. volatility is 8.53%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |